Getty Images

Top 25 Baseball Stories of 2016 — #19: Jenrry Mejia permanently suspended for a third positive PED test

3 Comments

We’re a few short days away from 2017 so it’s a good time to look back at the top 25 baseball stories of 2016. Some of them took place on the field, some of them off the field and some of them were creatures of social media, fan chatter and the like. No matter where the story broke, however, these were the stories baseball fans were talking about most this past year.

On April 11, 2015 Mets reliever Jenrry Mejía was suspended for 80 games after testing positive for use of stanozolol. It was his first ever positive drug test. He didn’t wait to long before his second positive test. In fact, he was still serving his suspension for his first offense when, on July 28, 2015, it was announced that Mejia had failed a test for stanozolol and boldenone to boot, giving him a 162-game suspension. The two suspensions, if fully served, would’ve made him ineligible until 100 games into the 2016 season. A season, by the way, in which the Mets figured Mejia would pitch. If not, they would not have agreed to a $2.47 million deal, prorated for the suspension, in January of this year.

There would be no 2016 in baseball for Mejia, however. Or 2017. And there likely will be no more baseball for Mejia again. That’s because two weeks after he signed his 2016 contract, Major League Baseball announced that Mejia had tested positive for boldenone once again. With his third positive test came a mandatory permanent ban under the Joint Drug Agreement. Mejia can apply for reinstatement at some point, but he will have to serve at least two years of a ban, making him ineligible until at least 2018 and possibly beyond. Given how long it will have been since he pitched by then, it’s not unreasonable to think that his career is over.

Mejia did not take the ban well. Instead, he lawyered up, claiming he was set up by Major League Baseball as part of a “witch hunt.” He claimed that the league fabricated his second and third positive drug tests and that the MLBPA did not sufficiently defend him. His lawyer further claimed that Major League Baseball works with third-party contractors to hack players’ social media accounts and uses the information it finds in PED investigations. Mejia vowed to fight his ban in court. To date Mejia has not filed any lawsuits. Nor has he claimed why, of all players, MLB would single him out in the way he claims they did.

Only one other player has tested positive for drugs three times in his career. That was Neifi Perez, who had three positive amphetamine tests. Those occurred several years ago before the penalties were as severe as they are now. As a result, Mejia is something of a trailblazer, becoming the first ever player to be permanently banned from baseball for performance enhancing drug use.

Mejia pitched 113 games in parts of five seasons and was never really that notable a player. He’ll certainly be remembered now.

Twins will not pick up Glen Perkins’ 2018 option

Stephen Dunn/Getty Images
Leave a comment

The Twins have informed reliever Glen Perkins they will not pick up his 2018 club option worth $6.5 million, MLB.com’s Rhett Bollinger reports. Instead, he will be paid $700,000 per his buyout clause.

Perkins, 34, has pitched a total of 7 2/3 innings over the last two seasons due to shoulder and biceps injuries. Bollinger adds that the two could come to terms on a minor league deal, but if they can’t reach an agreement, the lefty is likely to retire.

From 2011-15, Perkins emerged as one of the better relievers in baseball, making three All-Star teams. He compiled an aggregate 2.84 ERA with 340 strikeouts and 73 walks across 313 1/3 innings.